2023 International Congress Archives - Page 135 of 186

Predictive model for Identification of device-aided therapy (DAT) Candidates in Parkinson´s Disease (DELIST-PD Study)

E. Freire-Alvarez, I. Legarda Ramirez, R. Garcia-Ramos, F. Carrillo, D. Santos-Garcia, JC. Gomez-Esteban, JC. Martinez-Castrillo, I. Martinez-Torres, CJ. Madrid Navarro, MJ. Perez Navarro, F. Valero Garcia, B. Vives Pastor, L. Muñoz-Delgado, B. Tijero, C. Morata-Martinez, R. Aler, IM. Galvan, F. Escamilla-Sevilla (Elche, Spain)
Predictors of cognitive deficits in patients with idiopathic normal pressure hydrocephalus – a pilot MRI volumetric study

I. Straka, V. Bolekova, K. Cho, M. Jezberova, P. Brandoburova, P. Valkovic, Z. Kosutzka (Bratislava, Slovakia)
Predictors of death in Parkinson’s disease

M. Garon, L. Weis, F. Pistonesi, V. Cianci, N. Cazzola, ML. Nasi, R. Biundo, A. Antonini (padova, Italy)
Preliminary evidence for evolution of myoinositol and N-acteylaspartate as biomarkers of disease severity in early-stage multiple system atrophy

P. Trujillo, J. Iregui, K. Hett, A. Wynn, M. Donahue, C. Wong, D. Stamler, D. Claassen (Nashville, USA)
Preliminary report of cerebellar transcranial focused ultrasound for primary orthostatic tremor

J-F. Nankoo, T. Cortez Grippe, J. Ingratta, S. Mustafa, N. Raies, N. Drummond, G. Darmani, A. Lozano, R. Chen (Toronto, Canada)
Preliminary Report on Neuromelanin-Sensitive MRI Signal change after Allogeneic Bone marrow-derived Mesenchymal Stem Cells therapy: Phase IIa double-blind, randomized controlled trial

J. Suescun, M. Schiess, E. Rodarte, C. Adams, T. Ellmore (Houston, USA)
Preliminary Report on the efficacy of Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease: Phase IIa double-blind, randomized controlled trial.

M. Schiess, J. Suescun, C. Green, E. Tharp, S. Chandra, C. Adams, M. Shahnawaz, E. Rodarte, V. Thyne, T. Ellmore (Houston, USA)
Preliminary Report on the Safety and Tolerability of Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for Parkinson’s disease: Phase IIa double-blind, randomized controlled trial

J. Suescun, T. Ellmore, C. Adams, V. Thyne, E. Tharp, S. Chandra, C. Green, R. Shastri, J. Saltarrelli, M. Schiess (Houston, USA)
Preliminary results of the validation study of the Shame in Parkinson’s disease (SPARK) Scale

I. Debove, C. Rodriguez-Blazquez, S. Murcia, A. Zenger, MM. Kurtis, E. Cubo, C. Falup-Pecurariu, KR. Chaudhuri, H. Reichman, S. Bostantjopoulou, M. Bereau, V. Fleury, P. Krack (Bern, Switzerland)
Premenstrual worsening of UPDRS motor scale in women affected by Parkinson’s Disease

A. Thomas, D. Calisi, M. de Rosa, P. Ajdinaj, S. Sensi, M. Onodrj (Chieti, Italy)